Clinical Trials Directory

Trials / Recruiting

RecruitingNCT04992728

Prostate Assessment with Restriction Spectrum Imaging (RSI) MRI

Quantitative Diffusion MRI for Prostate Cancer Detection and Monitoring

Status
Recruiting
Phase
Study type
Observational
Enrollment
100 (estimated)
Sponsor
University of California, San Diego · Academic / Other
Sex
Male
Age
18 Years
Healthy volunteers
Not accepted

Summary

This single-center study will enroll 40 male participants to complete 2 diffusion magnetic resonance images within 30 days of each other.

Detailed description

Participants will undergo prostate MRI using a range of b-values and echo times. 40 participants will be invited to complete two such scans within 30 days of each other to evaluate reliability across time. Several advanced MRI models will be applied to the data, and the models will be assessed for accurate prediction of grade group ≥2 prostate cancer on histopathology, obtained through routine clinical care. We hypothesize that advanced, multi-compartment dMRI will yield a reliable, quantitative metric that is superior to standard ADC for detection of csPCa. RSI is a multicompartment model of diffusion MRI that uses data acquired at multiple b-values to distinguish varied diffusion speeds (restricted intracellular, hindered extracellular, and approximately free diffusion). The relative contributions of each compartment are estimated for each voxel in the imaging field of view. RSI cellularity index is a normalized parameter reflecting the contribution of very slow diffusion that is associated with tumor cellularity.

Conditions

Interventions

TypeNameDescription
OTHERRestricted Spectrum Magnetic Resonance ImaginingRestriction Spectrum Magnetic Resonance Imaging (RS-MRI), which uses magnetism instead of x-rays to build up a picture of the inside of the body. The scan is completely painless but can be rather noisy and requires the patient to lie very still inside the center of a large, doughnut-shaped magnet for approximately 30-60 minutes complete the imaging.

Timeline

Start date
2021-11-02
Primary completion
2025-11-01
Completion
2026-11-01
First posted
2021-08-05
Last updated
2025-02-06

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT04992728. Inclusion in this directory is not an endorsement.